3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES

Purpose: The prognostic significance of carotid-femoral pulse wave velocity (cfPWV) remains to be determined in patients with type 1 diabetes (T1D). We investigated the predictive value of cfPWV for various endpoints in T1D. Methods: At baseline, cfPWV was measured using the SphygmoCor device in 65...

Full description

Bibliographic Details
Main Authors: Tine Willum Hansen, Marie Frimodt-Møller, Simone Theilade, Nete Tofte, Tarun Veer Singh Ahluwalia, Peter Rossing
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125929986/view
_version_ 1818006116050665472
author Tine Willum Hansen
Marie Frimodt-Møller
Simone Theilade
Nete Tofte
Tarun Veer Singh Ahluwalia
Peter Rossing
author_facet Tine Willum Hansen
Marie Frimodt-Møller
Simone Theilade
Nete Tofte
Tarun Veer Singh Ahluwalia
Peter Rossing
author_sort Tine Willum Hansen
collection DOAJ
description Purpose: The prognostic significance of carotid-femoral pulse wave velocity (cfPWV) remains to be determined in patients with type 1 diabetes (T1D). We investigated the predictive value of cfPWV for various endpoints in T1D. Methods: At baseline, cfPWV was measured using the SphygmoCor device in 652 patients with T1D and various degrees of albuminuria. Endpoints were traced through National Registers and patient records and comprised: composite CVE, mortality, progression in albuminuria, and decline in estimated glomerular filtration rate (eGFR) ≥30%. Median follow-up ranged from 5.2 to 6.2 years. Slope estimates of eGFR and urinary albumin creatinine rate (UACR) were calculated for a median of 5.5 years. Adjustment included sex, age, mean arterial pressure, LDL cholesterol, smoking, HbA1c, UACR and eGFR at baseline. Hazard ratios (HR) were calculated per 1 standard derivation (SD) increase in cfPWV. Results: Of the 652 participants (56% male); mean±SD age was 54 ± 13 years and cfPWV 10.5 ± 3.38 m/s2. After adjustment, higher cfPWV was significantly associated with all endpoints: composite CVE (n = 81; HR:1.31; p = 0.045); mortality (n = 48; HR:1.39; p = 0.033); progression in albuminuria (n = 31; HR:1.16; p = 0.012); and decline in eGFR ≥ 30% (n = 90; HR: 1.39; p = 0.015).Higher cfPWV was associated with a steeper decline in eGFR and a steeper increase in UACR after adjustments (p ≤ 0.009). Conclusions: In patients with T1D, higher arterial stiffness was consistently associated with a higher risk of CVE, mortality and decline in renal function, independent of other risk factors. Measurement of cfPWV may have a promising role in risk stratification in T1D.
first_indexed 2024-04-14T04:55:47Z
format Article
id doaj.art-761394ff649241d384b8a38de3d37b19
institution Directory Open Access Journal
issn 1876-4401
language English
last_indexed 2024-04-14T04:55:47Z
publishDate 2018-12-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-761394ff649241d384b8a38de3d37b192022-12-22T02:11:08ZengBMCArtery Research1876-44012018-12-012410.1016/j.artres.2018.10.0383.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETESTine Willum HansenMarie Frimodt-MøllerSimone TheiladeNete TofteTarun Veer Singh AhluwaliaPeter RossingPurpose: The prognostic significance of carotid-femoral pulse wave velocity (cfPWV) remains to be determined in patients with type 1 diabetes (T1D). We investigated the predictive value of cfPWV for various endpoints in T1D. Methods: At baseline, cfPWV was measured using the SphygmoCor device in 652 patients with T1D and various degrees of albuminuria. Endpoints were traced through National Registers and patient records and comprised: composite CVE, mortality, progression in albuminuria, and decline in estimated glomerular filtration rate (eGFR) ≥30%. Median follow-up ranged from 5.2 to 6.2 years. Slope estimates of eGFR and urinary albumin creatinine rate (UACR) were calculated for a median of 5.5 years. Adjustment included sex, age, mean arterial pressure, LDL cholesterol, smoking, HbA1c, UACR and eGFR at baseline. Hazard ratios (HR) were calculated per 1 standard derivation (SD) increase in cfPWV. Results: Of the 652 participants (56% male); mean±SD age was 54 ± 13 years and cfPWV 10.5 ± 3.38 m/s2. After adjustment, higher cfPWV was significantly associated with all endpoints: composite CVE (n = 81; HR:1.31; p = 0.045); mortality (n = 48; HR:1.39; p = 0.033); progression in albuminuria (n = 31; HR:1.16; p = 0.012); and decline in eGFR ≥ 30% (n = 90; HR: 1.39; p = 0.015).Higher cfPWV was associated with a steeper decline in eGFR and a steeper increase in UACR after adjustments (p ≤ 0.009). Conclusions: In patients with T1D, higher arterial stiffness was consistently associated with a higher risk of CVE, mortality and decline in renal function, independent of other risk factors. Measurement of cfPWV may have a promising role in risk stratification in T1D.https://www.atlantis-press.com/article/125929986/view
spellingShingle Tine Willum Hansen
Marie Frimodt-Møller
Simone Theilade
Nete Tofte
Tarun Veer Singh Ahluwalia
Peter Rossing
3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
Artery Research
title 3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
title_full 3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
title_fullStr 3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
title_full_unstemmed 3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
title_short 3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
title_sort 3 7 pulse wave velocity is an independent risk factor for cardiovascular events mortality and decline in renal function in patients with type 1 diabetes
url https://www.atlantis-press.com/article/125929986/view
work_keys_str_mv AT tinewillumhansen 37pulsewavevelocityisanindependentriskfactorforcardiovasculareventsmortalityanddeclineinrenalfunctioninpatientswithtype1diabetes
AT mariefrimodtmøller 37pulsewavevelocityisanindependentriskfactorforcardiovasculareventsmortalityanddeclineinrenalfunctioninpatientswithtype1diabetes
AT simonetheilade 37pulsewavevelocityisanindependentriskfactorforcardiovasculareventsmortalityanddeclineinrenalfunctioninpatientswithtype1diabetes
AT netetofte 37pulsewavevelocityisanindependentriskfactorforcardiovasculareventsmortalityanddeclineinrenalfunctioninpatientswithtype1diabetes
AT tarunveersinghahluwalia 37pulsewavevelocityisanindependentriskfactorforcardiovasculareventsmortalityanddeclineinrenalfunctioninpatientswithtype1diabetes
AT peterrossing 37pulsewavevelocityisanindependentriskfactorforcardiovasculareventsmortalityanddeclineinrenalfunctioninpatientswithtype1diabetes